Skip to main content
. 2022 Jun 29;10(4):e00247-22. doi: 10.1128/spectrum.00247-22

FIG 1.

FIG 1

Evolution of P. aeruginosa toward tobramycin, ceftazidime, or ceftazidime-avibactam resistance in rich laboratory medium, urine, or SCFM. MICs for the antibiotic used as selective agent were determined every 5 days in populations that evolved 30 days in the presence of tobramycin, ceftazidime, or ceftazidime-avibactam in rich laboratory medium (RM), urine, or SCFM. Raw data for each evolved replicate are included in Tables S1 and S2.